Gheath Alatrash
Overview
Explore the profile of Gheath Alatrash including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1876
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rafaeli N, Costa D, Ledesma C, Jain N, Tewari P, Khouri I, et al.
Clin Lymphoma Myeloma Leuk
. 2025 Feb;
PMID: 39955258
No abstract available.
2.
Shi C, Tian Z, Yan J, Zhang M, Sukhumalchandra P, Chang E, et al.
Leukemia
. 2025 Feb;
PMID: 39939820
Myeloid azurophil granules provide a rich source of intracellular leukemia antigens. Cathepsin G (CG) is a serine protease that has higher expression in acute myeloid leukemia (AML) blasts in comparison...
3.
He H, Vedia R, Lu S, Li Q, Cox K, St John L, et al.
Cytotherapy
. 2024 Jul;
26(11):1331-1340.
PMID: 39033444
Background Aims: Hu8F4 is a T-cell receptor-like antibody with high affinity for the leukemia-associated antigen PR1/HLA-A2 epitope. Adapted into a chimeric antigen receptor (CAR) format, Hu8F4-CAR is composed of the...
4.
Molldrem J, He H, Vedia R, Lu S, Li Q, Cox K, et al.
Res Sq
. 2024 Mar;
PMID: 38464203
Hu8F4 is a T cell receptor (TCR)-like antibody with high affinity for leukemia-associated antigen PR1/HLA-A2 epitope. Adapted into a chimeric antigen receptor (CAR) format, Hu8F4-CAR is comprised of the Hu8F4...
5.
Malek A, Al-Juhaishi T, Milton D, Ramdial J, Daher M, Olson A, et al.
Bone Marrow Transplant
. 2024 Feb;
59(5):699-704.
PMID: 38355908
No abstract available.
6.
Goldberg J, Qiao N, Guerriero J, Gross B, Meneksedag Y, Lu Y, et al.
Cancer Res Commun
. 2024 Feb;
4(2):496-504.
PMID: 38335301
Significance: Estrogen receptor (ESR1) mutations have emerged as a key factor in endocrine therapy resistance. We identified and validated five novel, immunogenic ESR1-derived peptides that could be targeted through vaccine-based...
7.
Parra E, Zhang J, Duose D, Gonzalez-Kozlova E, Redman M, Chen H, et al.
Clin Cancer Res
. 2024 Jan;
30(8):1655-1668.
PMID: 38277235
Purpose: Identifying molecular and immune features to guide immune checkpoint inhibitor (ICI)-based regimens remains an unmet clinical need. Experimental Design: Tissue and longitudinal blood specimens from phase III trial S1400I...
8.
Marcoux C, Saliba R, Wallis W, Khazal S, Ragoonanan D, Rondon G, et al.
Blood Adv
. 2024 Jan;
8(5):1128-1136.
PMID: 38266155
Veno-occlusive disease (VOD) is a rare but potentially life-threatening complication after allogeneic hematopoietic stem cell transplantation (allo-SCT). Although increasing awareness and modern transplant techniques have mitigated risk, the interaction of...
9.
Desai P, Wang B, Fonseca A, Borges P, Jelloul F, Reville P, et al.
Cancer Immunol Res
. 2023 Jun;
:OF1-OF18.
PMID: 37285177
Comprehensive investigation of CD8+ T cells in acute myeloid leukemia (AML) is essential for developing immunotherapeutic strategies beyond immune checkpoint blockade. Herein, we performed single-cell RNA profiling of CD8+ T...
10.
OShea A, Clifton G, Qiao N, Heckman-Stoddard B, Wojtowicz M, Dimond E, et al.
Cancer Prev Res (Phila)
. 2023 Jun;
16(6):333-341.
PMID: 37259799
Prevention Relevance: This trial showed that vaccination of patients with HLA-A2-positive DCIS with NeuVax in the preoperative setting can induce a sustained antigen-specific T-cell response. This provides proof of principle...